Amplia Therapeutics Limited
ASX:ATX.AX
0.068 (AUD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2013 Q4 | 2013 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.004 | 2.448 | -0.58 | 1.769 | 1.221 | 0.763 | 0.674 | 0.86 | 0.034 | 0 | -0 | 0.051 | -0.077 | 0.657 | 0.616 | 1.182 | 1.447 | 0.817 | 0.015 | 0.015 | 0 | 0 | 0 |
| Cost of Revenue
| 0.331 | 0.043 | 0.044 | 0.029 | 0.002 | 0.002 | 0 | 0 | 0 | 0 | 0.079 | 0.077 | 0.022 | 0.08 | 0.075 | 0.131 | 0.114 | 0.136 | 0.119 | 0.119 | 0 | 0.118 | 0.118 |
| Gross Profit
| 1.674 | 2.405 | -0.624 | 1.74 | 1.219 | 0.761 | 0.673 | 0.86 | 0.034 | -0 | -0.079 | -0.026 | -0.1 | 0.577 | 0.541 | 1.051 | 1.332 | 0.681 | -0.104 | -0.104 | 0 | -0.118 | -0.118 |
| Gross Profit Ratio
| 0.835 | 0.982 | 1.077 | 0.984 | 0.999 | 0.998 | 0.999 | 1 | 0.988 | 0 | 187.19 | -0.511 | 1.291 | 0.878 | 0.879 | 0.889 | 0.921 | 0.834 | -6.852 | -6.852 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 3.611 | 2.194 | 1.158 | 3.529 | 2.471 | 1.302 | 1.461 | 0.75 | 0.758 | 0.313 | 0.542 | 0.136 | 1.196 | 2.029 | 3.148 | 2.888 | 3.305 | 1.442 | 1.021 | 1.021 | 0.324 | 0.387 | 0.387 |
| General & Administrative Expenses
| 1.389 | 1.215 | 1.205 | 0.993 | 0.904 | 0.732 | 0.634 | 0.501 | 0.406 | 0.453 | 0.394 | 0.467 | 0.538 | 0.815 | 0.731 | 0.733 | 0.628 | 0.619 | 0.801 | 0.801 | 0.873 | 0.363 | 0.363 |
| Selling & Marketing Expenses
| 0.04 | 0.158 | 0.388 | 0.128 | 0.165 | 0.05 | 0.351 | 0.177 | 0.205 | 0.122 | 0.147 | 0.097 | 0.034 | 0.158 | 0.144 | 0.153 | 0.142 | 0.129 | 0.07 | 0.07 | 0 | 0.107 | 0.107 |
| SG&A
| 1.429 | 1.373 | 1.594 | 1.121 | 1.069 | 0.782 | 0.985 | 0.678 | 0.611 | 0.575 | 0.541 | 0.564 | 0.575 | 1.045 | 1.049 | 1.641 | 0.852 | 0.895 | 0.801 | 0.801 | -0.214 | 0.47 | 0.47 |
| Other Expenses
| -0.023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.015 | 0.015 | 0 | 0 | 0 |
| Operating Expenses
| 5.016 | 3.567 | 2.752 | 4.65 | 3.54 | 2.084 | 2.446 | 1.428 | 1.37 | 0.889 | 1.084 | 0.701 | 1.713 | 3.089 | 4.183 | 4.547 | 4.177 | 2.854 | 2.715 | 2.715 | 0.11 | 1.29 | 1.29 |
| Operating Income
| -3.342 | -3.61 | -2.796 | -4.679 | -3.542 | -2.085 | -2.446 | -1.429 | -1.37 | -0.889 | -1.163 | -0.727 | -1.813 | -2.512 | -3.642 | -3.496 | -2.844 | -2.173 | -2.699 | -2.699 | -2.044 | -1.515 | -1.515 |
| Operating Income Ratio
| -1.668 | -1.474 | 4.822 | -2.644 | -2.901 | -2.735 | -3.632 | -1.661 | -40.032 | 0 | 2,756.372 | -14.285 | 23.517 | -3.821 | -5.914 | -2.957 | -1.966 | -2.661 | -178.107 | -178.107 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -2.021 | 0.032 | 0.046 | 0.039 | -0.001 | 0 | -0.162 | 0.057 | 0.002 | 0.004 | 0.011 | 0.008 | 0.011 | 0.001 | 0.048 | -0.004 | 0.036 | 0.038 | 0.081 | 0.081 | -0.203 | -0.179 | -0.179 |
| Income Before Tax
| -5.364 | -3.578 | -2.751 | -4.64 | -3.542 | -2.085 | -2.444 | -1.371 | -1.368 | -0.885 | -1.152 | -0.718 | -1.802 | -2.495 | -3.594 | -3.482 | -2.808 | -2.135 | -2.619 | -2.619 | -2.248 | -1.694 | -1.694 |
| Income Before Tax Ratio
| -2.676 | -1.461 | 4.743 | -2.622 | -2.902 | -2.735 | -3.628 | -1.594 | -39.981 | 0 | 2,730.227 | -14.103 | 23.379 | -3.796 | -5.836 | -2.945 | -1.941 | -2.615 | -172.787 | -172.787 | 0 | 0 | 0 |
| Income Tax Expense
| -1.989 | -2.448 | 0.58 | -1.728 | -1.221 | -0.763 | -0.674 | -0.86 | -0.034 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.081 | -0.081 | 0.043 | 0 | 0 |
| Net Income
| -3.374 | -1.129 | -3.331 | -2.912 | -2.322 | -1.323 | -1.77 | -0.511 | -1.334 | -0.885 | -1.152 | -0.718 | -1.802 | -2.495 | -3.594 | -3.482 | -2.808 | -2.135 | -2.619 | -2.619 | -2.248 | -1.694 | -1.694 |
| Net Income Ratio
| -1.683 | -0.461 | 5.743 | -1.646 | -1.902 | -1.735 | -2.628 | -0.594 | -38.981 | 0 | 2,730.227 | -14.103 | 23.379 | -3.796 | -5.836 | -2.945 | -1.941 | -2.615 | -172.787 | -172.787 | 0 | 0 | 0 |
| EPS
| -0.017 | -0.006 | -0.017 | -0.015 | -0.014 | -0.011 | -0.016 | -0.006 | -0.018 | -0.017 | -0.028 | -0.019 | -0.08 | -0.11 | -0.16 | -0.17 | -0.15 | -0.12 | -0.13 | -0.13 | -0.174 | -0.1 | -0.1 |
| EPS Diluted
| -0.017 | -0.006 | -0.017 | -0.015 | -0.014 | -0.011 | -0.016 | -0.006 | -0.018 | -0.017 | -0.028 | -0.019 | -0.08 | -0.11 | -0.16 | -0.17 | -0.15 | -0.12 | -0.13 | -0.13 | -0.174 | -0.1 | -0.1 |
| EBITDA
| -3.441 | -1.118 | -2.669 | -2.88 | -3.54 | -2.084 | -2.443 | -1.428 | -1.37 | -0.885 | -1.162 | -0.726 | -1.808 | -2.496 | -3.622 | -3.478 | -2.793 | -1.656 | -1.844 | -1.844 | -1.264 | -0.742 | -0.742 |
| EBITDA Ratio
| -1.717 | -1.457 | 4.746 | -2.628 | -2.9 | -2.733 | -3.631 | -1.661 | -40.02 | 0 | 2,754.488 | -14.269 | 23.454 | -3.797 | -5.882 | -2.942 | -1.93 | -2.028 | -121.689 | -121.689 | 0 | 0 | 0 |